Ohsaka Akimichi, Shiina Shigeo, Kobayashi Masaru, Kudo Hideyuki, Kawaguchi Ryuji
Department of Transfusion Medicine, Juntendo University School of Medicine, Tokyo.
Intern Med. 2002 Dec;41(12):1183-7. doi: 10.2169/internalmedicine.41.1183.
We describe a case of Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML) expressing p190(BCR-ABL). Reverse transcription-polymerase chain reaction (RT-PCR) analysis of bone marrow cells showed a 472-bp band using primers specific for the p190(BCR-ABL) but not p210(BCR-ABL) transcript. Sequencing analysis revealed that the PCR product was derived from the fusion between BCR exon e1 and ABL exon a2 (e1a2). CML expressing p190(BCR-ABL) is relatively rare. In a review of the literature, it may be grouped into 2 categories; approximately half of the patients exhibited prominent monocytosis and intermediate hematological phenotype between CML and chronic myelomonocytic leukemia, and the remaining patients showed no monocytosis.
我们描述了一例表达p190(BCR-ABL)的费城染色体阳性慢性髓性白血病(Ph阳性CML)。使用针对p190(BCR-ABL)而非p210(BCR-ABL)转录本的特异性引物对骨髓细胞进行逆转录聚合酶链反应(RT-PCR)分析,显示出一条472bp的条带。测序分析表明,PCR产物源自BCR外显子e1与ABL外显子a2(e1a2)之间的融合。表达p190(BCR-ABL)的CML相对罕见。在文献综述中,它可分为2类;大约一半的患者表现出显著的单核细胞增多以及介于CML和慢性粒单核细胞白血病之间的中间血液学表型,其余患者则无单核细胞增多表现。